| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2851128 | American Heart Journal | 2010 | 8 Pages |
Abstract
The Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study will test the hypothesis that therapy guided by NT-proBNP concentrations will be superior to standard of care HF management (www.clinicaltrials.gov identifier NCT00351390).
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anju MD, Shafiq U. MD, Asim MD, Aaron L. MD, Stephanie A. MD, James L. MD,